Viral infections and diabetes

Advances in Experimental Medicine and Biology

Volumn 771, Issue , 2013, Pages 252-271

  Galleri, Letizia ^a,b   Sebastiani, Guido ^a,b   Vendrame, Francesco ^b,c   Grieco, Fabio Arturo ^a,b   Spagnuolo, Isabella ^a,b   Dotta, Francesco ^a,b  

^a UNIVERSITY OF SIENA   (Italy)

^b Fondazione Umberto Di Mario ONLUS   (Italy)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BOVINE VIRAL DIARRHEA MUCOSAL DISEASE VIRUS; CELL DAMAGE; CELL DEATH; COXSACKIE VIRUS A; COXSACKIE VIRUS B; CYTOMEGALOVIRUS; DIABETOGENESIS; ENCEPHALOMYOCARDITIS VIRUS; ENVIRONMENTAL FACTOR; FOOT AND MOUTH DISEASE VIRUS; HEREDITY; HUMAN; HUMAN PARVOVIRUS B19; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KILHAM RAT VIRUS; LJUNGAN VIRUS; MENGO VIRUS; MUMPS VIRUS; NONHUMAN; PANCREAS ISLET BETA CELL; PARECHOVIRUS; PARVOVIRUS; REOVIRUS; RETROVIRUS; ROTAVIRUS; RUBELLA VIRUS; TOGAVIRUS; VIRUS INFECTION; ANIMAL; GENETIC PREDISPOSITION; GENETICS; REVIEW; RISK FACTOR; VIROLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK FACTORS; VIRUS DISEASES;

MLCS; MLOWN;

EID: 84907810119     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4614-5441-0_20     Document Type: Article

References (100)

1. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011; 342:d35.
2. Yin H, Berg AK, Tuvemo T et al. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 2002; 51:1964-1971.
3. Nejentsev S, Howson JM, Walker NM et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007; 450:887-892.
4. Pugliese A, Zeller M, Fernandez A Jr et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997; 15:293-297.
5. Concannon P, Rich SS, Nepom GT. Genetics of type la diabetes. N Engl J Med 2009; 360:1646-1654.
6. Anjos SM, Tessier MC, Polychronakos C. Association of the cytotoxic T-lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. J Clin Endocrinol Metab 2004; 89:6257-6265.
7. Nejentsev S, Walker N, Riches D et al. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009; 324:387-389.
8. Field LL, Bonnevie-Nielsen V, Pociot F et al. OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. Diabetes 2005; 54:1588-1591.
9. Skarsvik S, Puranen J, Honkanen J et al. Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes. Diabetes 2006; 55:996-1003.
10. Dotta F, Censini S, Van Halteren AG et al. Coxsackie B4 virus infection of |3 cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 2007; 104:5115-5120.
11. Seewaldt S, Thomas HE, Ejrnaes M et al. Virus-induced autoimmune diabetes: most beta cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes 2000;49:1801-1809.
12. Lang KS, Recher M, Junt T et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 2005; 11:138-145.
13. Jun HS, Yoon JW. A new look at viruses in type 1 diabetes. Diabetes Metab Res Rev 2003; 19:8-31.
14. Horwitz MS, Fine C, Ilic A et al. Requirements for viral-mediated autoimmune diabetes: beta-cell damage and immune infiltration. J Autoimmun 2001; 16:211-217.
15. Horwitz MS, Ilic A, Fine C et al. Presented antigen from damaged pancreatic beta cells activates autoreactive T-cells in virus-mediated autoimmune diabetes. J Clin Invest 2002; 109:79-87.
16. Atkinson MA, Bowman MA, Campbell L et al. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994; 94:2125-2129.
17. Tian J, Lehmann PV, Kaufman DL. T-cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. JExp Med 1994; 180:1979-1984.
18. Sevilla N, Homann D, Von Herrath M et al. Virus-induced diabetes in atransgenic model: role of cross-reacting viruses and quantitation of effector T-cells needed to cause disease. J Virol 2000; 74:3284-3292.
19. Christen U, Edelmann KH, McGavern DB et al. A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. J Clin Invest 2004; 114:1290-1298.
20. Grieco FA, Vendrame F, Spagnuolo I et al. Innate immunity and the pathogenesis of type 1 diabetes. Semin Immunopathol 2011; 33:57-66.
21. Verdijk RM, Mutis T, Esendam B et al. Polyriboinosinic polyribocytidylic acid (poly (I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol 1999; 163:57-61.
22. Mattei F, Schiavoni G, Belardelli F et al. IL-15 is expressed by dendritic cells in response to type IIFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol 2001; 167:1179-1187.
23. Liu D, Cardozo AK, Darville MI et al. Double-stranded RNA cooperates with interferon-gamma and IL-1 beta to induce both chemokine expression and nuclear factor-kappa B-dependent apoptosis in pancreatic beta-cells: potential mechanisms for viral-induced insulitis and beta-cell death in type 1 diabetes mellitus. Endocrinology 2002; 143:1225-1234.
24. Blair LA, Heitmeier MR, Scarim AL et al. Double-stranded RNA-dependent protein kinase is not required for double-stranded RNA-induced nitric oxide synthase expression or nuclear factor-kappaB activation by islets. Diabetes 2001; 50:283-290.
25. Sobel DO, Goyal D, Ahvazi B et al. Low dose poly I:C prevents diabetes in the diabetes prone BB rat. J Autoimmun 1998; 11:343-352.
26. Zhou R, Wei H, Tian Z. NK3-like NK cells are involved in protective effect of polyinosinic-polycytidylic acid on type 1 diabetes in nonobese diabetic mice. J Immunol 2007; 178:2141-2147.
27. Jaïdane H, Sane F, Gharbi J et al. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab Res Rev 2009; 25:591-603.
28. Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 2010; 6:279-289.
29. Holmberg R, Klitz W, Blixt M et al. Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats. Microbiol Immunol 2009; 53:567-572.
30. Tapia G, Cinek O, Rasmussen T et al. Longitudinal study of Parechovirus infection in infancy and risk of repeated positivity for multiple islet autoantibodies: the MIDIA Study. Pediatr Diabetes 2011; 12:58-62.
31. Van der Werf N, Kroese FG, Rozing J et al. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev 2007; 23:169-183.
32. Menser MA, Forrest JM, Bransby RD. Rubella infection and diabetes mellitus. Lancet 1978; 1:57-60.
33. Serreze DV, Leiter EH, Kuff EL et al. Molecular mimicry between insulin and retroviral antigen p73. Development of cross-reactive autoantibodies in sera of NOD and C57BL/KsJ db/db mice. Diabetes 1988;37:351-358.
34. Conrad B, Weissmahr RN, Boni J et al. A human endogenous retroviral superantigenas candidate autoimmune gene in type 1 diabetes. Cell 1997; 90:303-313.
35. Wetzel JD, Barton ES, Chappell JD et al. Reovirus delays diabetes onset but does not prevent insulitis in nonobese diabetic mice. J Virol 2006; 80:3078-3082.
36. Graham KL, O'Donnell J A, Tan Y et al. Rotavirus infection of infant and young adult nonobese diabetic mice involves extraintestinal spread and delays diabetes onset. J Virol 2007; 81:6446-6458.
37. Graham KL, Sanders N, Tan Y et al. Rotavirus infection accelerates type 1 diabetes in mice with established insulitis. J Virol 2008; 82:6139-6149.
38. Coulson BS, Witterick PD, Tan Y et al. Growth of rotaviruses in primary pancreatic cells. J Virol 2002; 76:9537-9544.
39. Honeyman MC, Coulson BS, Stone NJ. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000; 49:1319-1323.
40. Munakata Y, Kodera T, Saito T et al. Rheumatoid arthritis, type 1 diabetes, and Graves' disease after acute parvovirus bl9 infection. Lancet 2005; 366:780.
41. Tirabassi RS, Guberski DL, Blankenhorn EP et al. Infection with viruses from several families triggers autoimmune diabetes in L.E.W.∗1WR1 rats: prevention of diabetes by maternal immunization. Diabetes 2010; 59:110-118.
42. Oldstone MB. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 1988; 239:500-502.
43. Roivainen M, Klingel K. Virus infections and type 1 diabetes risk. Curr Diab Rep 2010; 10:350-356.
44. Kitamura N, Semler BL, Rothberg PG et al. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature 1981; 291:547-553.
45. Tauriainen S, Salminen H, Hyöty. Can enteroviruses cause type 1 diabetes? Ann N Y Acad Sci 2003; 1005:13-22.
46. Jaïdane H, Hober D. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab 2008; 34:537-548.
47. Webb SR, Loria RM, Madge GE et al. Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene. J Exp Med 1976; 143:1239-1248.
48. Loria RM, Montgomery LB, Corey LA et al. Influence of diabetes mellitus heredity on susceptibility to coxsackievirus B4. Arch Virol 1984; 81:251-262.
49. Loria RM, Montgomery LB, Tuttle-Fuller N et al. Genetic predisposition to diabetes mellitus is associated with impaired humoral immunity to coxsackievirus B4. Diabetes Res Clin Pract 1986; 2:91-96.
50. Yoon JW, London WT, Curfman BL et al. Coxsackie virus B4 produces transient diabetes in nonhuman primates. Diabetes 1986; 35:712-716.
51. Elshebani A, Olsson A, Westman J et al. Effects on isolated human pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes. Virus Res 2007; 124:193-203.
52. Flodstrom M, Tsai D, Fine C et al. Diabetogenic potential of human pathogens uncovered in experimentally permissive beta-cells. Diabetes 2003; 52:2025-2034.
53. Härkönen T, Lankinen H, Davydova B et al. Enterovirus infection can induce immune responses that cross-react with beta-cell autoantigen tyrosine phosphatase IA-2/IAR. J Med Virol 2002; 66:340-350.
54. Fujinami RS, von Herrath MG, Christen U et al. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 2006; 19:80-94.
55. Gronski MA, Boulter JM, Moskophidis D et al. TCR affinity and negative regulation limit autoimmunity. Nat Med 2004; 10:1234-1239.
56. Horwitz MS, Bradley LM, Harbertson J et al. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998; 4:781-785.
57. Serreze DV, Ottendorfer EW, Ellis TM et al. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 2000; 49:708-711.
58. Drescher KM, Kono K, Bopegamage S et al. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 2004; 329:381-394.
59. Tracy S, Drescher KM, Chapman NM et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 2002; 76:12097-12111.
60. Jun HS, Yoon CS, Zbytnuik L et al. The role of macrophages in T-cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med 1999; 189:347-358.
61. Horwitz MS, Ilic A, Fine C et al. Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells. Clin Immunol 2004; 110:134-144.
62. Serreze DV, Wasserfall C, Ottendorfer EW et al. Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon. J Virol 2005; 79:1045-1052.
63. Filippi CM, Ehrhardt K, Estes EA et al. TLR2 signaling improves immunoregulation to prevent type 1 diabetes. Eur J Immunol 2011; 41:1399-1409.
64. Filippi CM, Estes EA, Oldham JE et al. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J Clin Invest 2009; 119:1515-1523.
65. Berger MM, See DM, Aymard M et al. Demonstration of persistent enterovirus in the pancreas of diabetic mice by in situ polymerase chain reaction. Clin Diagn Virol 1998; 9:141-143.
66. See DM, Tilles JG. Pathogenesis of virus-induced diabetes in mice. J Infect Dis 1995; 171:1131-1138.
67. Richardson SJ, Willcox A, Bone AJ et al. The prevalence of enteroviral capsid protein VP-1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009; 52:1143-1151.
68. Ylipaasto P, Klingel K, Lindberg AM et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 2004; 47:225-239.
69. Szopa TM, Dronfield DM, Ward T et al. In vivo infection of mice with Coxsackie B4 virus induces long-term functional changes in pancreatic islets with minimal alteration in blood glucose. Diabet Med 1989;6:314-319.
70. Richer MJ, Lavallée DJ, Shanina I et al. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS One 2009; 4:e4127.
71. Mukherjee A, Morosky SA, Delorme-Axford E et al. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 2011;7:el001311.
72. Guberski DL, Thomas VA, Shek WR et al. Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Worrats. Science 1991;254:1010-1013.
73. Blankenhorn EP, Rodemich L, Martin-Fernandez C et al. The rat diabetes susceptibility locus Iddm4 and at least one additional gene are required for autoimmune diabetes induced by viral infection. Diabetes 2005;54:1233-1237
74. Brown DW, Welsh RM, Like AA. Infection of peripancreatic lymph nodes but not islets precedes Kilham rat virus-induced diabetes in BB/Wor rats. J Virol 1993; 67:5873-5878.
75. Chung YH, Jun HS, Son M et al. Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J Immunol 2000; 165:2866-2876.
76. Zipris D, Hillebrands JH, Welsh RM et al. Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T-cell populations. J Immunol 2003; 170:3592-3602.
77. Mendez II, Chung YH, Jun HS et al. Immunoregulatory role of nitric oxide in Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J Immunol 2004; 173:1327-1335.
78. Zipris D, Lien E, Xie JX et al. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J Immunol 2005; 174:131-142.
79. Zipris D, Lien E, Nair A et al. TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat. J Immunol 2007; 178:693-701.
80. Wolter TR, Wong R, Sarkar SA et al. DNA microarray analysis for the identification of innate immune pathways implicated in virus-induced autoimmune diabetes. Clin Immunol 2009; 132:103-115.
81. Hillebrands JL, van der Werf N, Klatter FA et al. Role of peritoneal macrophages in cytomegalovirus-induced acceleration of autoimmune diabetes in BB-rats. Clin Dev Immunol 2003; 10:133-139.
82. Mordes JP, Bortell R, Doukas J et al. The BB/Wor rat and the balance hypothesis of autoimmunity. Diabetes Metab Rev 1996; 12:103-109.
83. Mordes JP, Guberski DL, Leif JH et al. LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation. Diabetes 2005; 54:2727-2733.
84. Hermann R, Knip M, Veijola R et al. Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes-indication of an increased environmental pressure? Diabetologia2003; 46:420-425.
85. Fourlanos S, Varney MD, Tait BD et al. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 2003; 31:1546-1549.
86. DIAMOND Project Group, Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med 2006;23:857-866.
87. Viskari H, Paronen J, Keskinen P. Humoral beta cell autoimmunity is rare in patients with congenital rubella. Clin Exp Immunol 1978; 133:378-383.
88. Gamble DR, Kinsley MJ, Fitzgerald MG et al. Viral Antibodies in diabetes mellitus. BMJ 1969; 3:627-630.
89. Lönnrot M, Korpela K, Knip M et al. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes 2000;49:1314-1318.
90. Chehadeh W, Weill J, Vantyghem MC et al. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J Infect Dis 2000; 181:1929-1939.
91. Chehadeh W, Kerr-Conte J, Pattou F et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol 2000; 74:10153-10164.
92. Yoon JW, Austin M, Onodera T et al. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300:1173-1179.
93. Eizirik DL, Mandrup-Poulsen T. A choice of death- the signal transduction of immune mediated beta-cell apoptosis. Diabetologia 2001; 44:2115-2133.
94. Ylipaasto P, Kutlu B, Rasilainen S et al. Global profiling of coxsakievirus- and cytokine-induced gene expression in human pancreatic islets. Diabetologia 2005; 48:1510-1522.
95. Berg AK, Tuvemo T, Frisk G. Enterovirus markers and serum CXCL10 in children with type 1 diabetes. J Med Virol 2010; 82:1594-1599.
96. Vreugdenhil GR, Geluk A, Ottenhoff TH et al. Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses andbinds to the diabetes associated HLA-DR3 molecule. Diabetologia 1998; 41:40-46.
97. Härkönen T, Lankinen H, Davydova B et al. Enterovirus infection can induce immune responses that cross-react with beta-cell autoantigen tyrosine phosphatase IA-2/IAR. J Med Virol 2002; 66:340-350.
98. Honeyman MC, Stone NL, Falk BA et al. Evidence for molecular mimicry between human T-cell epitopes in rotavirus and pancreatic islet autoantigens. J Immunol 2010; 184:2204-2210.
99. Wen L, Ley RE, Volchkov PV et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008; 455:1109-1113.
100. Calcinaro F, Dionisi S, Marinaro M et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 2005; 48:1565-1575.